Security key
45783C200
Instil Bio, Inc. - Common stock, par value $ 0.000001 per share (TIL)
CUSIP: 45783C200
Q4 2023 13F Holders as of 31 Dec 2023
- Security type / class
- Equity / Common stock, par value $ 0.000001 per share
- Total 13F shares
- 2,037,306
- Total 13F value
- $15,523,621
- Share change
- +1,779,209
- SEC-reported price per share
- $7.62
- Number of holders
- 27
- Value change
- +$13,556,922
- Number of buys
- 26
- Shares outstanding
- 6,505,400
Holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2023
Institutions
27
Top holders
10
TIL full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
Instil Bio, Inc. SEC filings
Instil Bio, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 45783C200
Recent filing periods:
Ownership snapshot
Top reported holders of TIL - Instil Bio, Inc. - Common stock, par value $ 0.000001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Curative Ventures V LLC
Disclosed value leader
Curative Ventures V LLC
Comparable rows
0/15
Latest evidence
30 Sep 2023
13F
Highest disclosed value: $16,255,471
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
Curative Ventures V LLC has the largest disclosed position value at $16.26M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Curative Ventures V LLC's linked filing trail.
Disclosed position value
Top 5
Curative Ventures V LLC
$16.26M
Vivo Capital, LLC
$5.34M
CPMG Inc
$3.52M
BAKER BROS. ADVISORS LP
$2.01M
VANGUARD GROUP INC
$1.14M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Curative Ventures V LLC |
13F
Company
|
—
denominator unverified
|
$16,255,471
37,980,073 shares
|
— | 30 Sep 2023 |
| Vivo Capital, LLC |
13F
Company
|
—
denominator unverified
|
$5,344,345
12,486,787 shares
|
— | 30 Sep 2023 |
| CPMG Inc |
13F
Company
|
—
denominator unverified
|
$3,517,504
8,218,467 shares
|
— | 30 Sep 2023 |
| BAKER BROS. ADVISORS LP |
13F
Company
|
—
denominator unverified
|
$2,013,481
4,704,395 shares
|
— | 30 Sep 2023 |
| VANGUARD GROUP INC |
13F
Company
|
—
denominator unverified
|
$1,143,877
2,672,610 shares
|
— | 30 Sep 2023 |
| Western Standard LLC |
13F
Company
|
—
denominator unverified
|
$769,110
1,796,987 shares
|
— | 30 Sep 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
27
Shares
2,037,306
Rows available
27
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2023 vs Q2 2026 Across Filers
Q2 2026 holders
25
Q4 2023 holders
27
Holder diff
2
| Investor | Q2 2026 Shares | Q4 2023 Shares | Share Diff | Share Chg % | Q2 2026 value | Q4 2023 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend